For Pharma and Biotech companies, the importance of maintaining regulatory compliance cannot not be understated, especially when working in the area of patient communication.  I work to an ethos of ethical compliance, due diligence and added value, always with an eye to the resources available. 

​

The three keys  to building successful compliant patient engagement partnerships are:

​

1. Transparency

2. Project Rationale 

3. Project Ownership  

 

I was the principal author of a peer review publication which identified these three elements as the most important  determinants of  a compliant Phase III advocacy strategy as seen by Industry and Patient Groups themselves. ​

Journal Market Access and Health Policy 2016 4 33177

​

​

 

 

​